Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events
The complexity of the humoral immune response against HLA antigens
Early death after kidney transplantation - can the risk be reduced?
Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies
Death within the first year after kidney transplantation – an observational cohort study
Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation
Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation
Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation
A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts
Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation
Laudatio to Professor Christian Cabrol honorary member of ESOT
Long-term outcomes after deceased donor renal transplantation in patients with genitourinary tuberculosis
Neutropenia associated with antihuman neutrophil antibodies following allogeneic hematopoietic stem cell transplantation
Allotransplantation of kidney from unrelated living donor with loin pain haematuria syndrome